FDA Inspection
Southern Blood Services IncSouthern Blood Services Inc – FDA Inspection, Nov 15, 2019
Record Details
This FDA Inspection record concerns Southern Blood Services Inc, with an inspection on November 15, 2019, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Southern Blood Services Inc
- Inspection Date
- November 15, 2019
- Product Type
- Biologics
View Company Profile
ID · d3af5625-6982-4605-9ad5-a63de68e9d23
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1109982
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
2- 21 CFR 630.10(h)Ineligible Donor
- 21 CFR 606.100(b)(15)Schedules and procedures for equipment & calibration
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Southern Blood Services Inc
8| Date | Classification | Office | Project area |
|---|---|---|---|
| February 3, 2026 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| April 6, 2023 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| October 17, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| December 14, 2015 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| December 5, 2013 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Southern Blood Services Inc
- FDA Inspection 1302094 - 2026-02-03
- FDA Inspection 1201999 - 2023-04-06
- FDA Inspection 1029680 - 2017-10-17
- FDA Inspection 951746 - 2015-12-14
- FDA Inspection 859247 - 2013-12-05
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.